Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
-
ProKidney to Participate in the Jefferies Global Healthcare Conference
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
-
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
-
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
-
Plymouth Industrial REIT to Present at Nareit’s REITweek 2024
-
Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
-
Bitfarms Responds to Unsolicited Proposal from Riot Platforms
-
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases
-
Cielo Announces Appointment of New Auditor
-
Athira Pharma to Participate in Upcoming June Conferences
-
Dragonfly Energy to Participate in June 2024 Conferences
-
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
-
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
-
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
-
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
-
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
-
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024
-
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
-
OTC Markets Group Welcomes Verde Agritech Ltd. to OTCQX
-
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
-
OTC Markets Group Welcomes Marpai, Inc. to OTCQX
-
Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
-
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
-
IGM Biosciences to Present at the Jefferies Healthcare Conference
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
-
"Charm of Jiangsu" International Photography Project: Experiencing the Flavor of Happiness
-
"Charm of Jiangsu" International Photography Project: Experiencing the Flavor of Happiness
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Castellum, Inc. Announces Leadership Changes
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Audit Committee Chair Confirmation
-
Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer
-
Cybersecurity Skills Shortage Is Ranked as the Biggest Risk to MSPs and Their Clients
-
Global 50 Manufacturing Giant Trusts eGain for Knowledge-Powered Customer Service
-
Radisson Expands Drill Program to 35,000 Metres at the O’Brien Gold Project in Quebec
-
Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system
-
FusionX Introduces Onchain Perpetual Futures Trading to Mantle Users
-
Net Asset Value(s)
-
Spectora Announces Exclusive Technology Partnership with LaunchPad Home Group to Drive Growth Across Portfolio of Home Inspection Companies
